Apollo Hospitals Share Price Surges 6% to Record High on Robust Q1 Results

Apollo Hospitals share price gained over 6% on Wednesday, August 13, after the company reported a strong performance in the April-June quarter of fiscal 2025-26 (Q1FY26). The stock hit a record high during the session, with brokerages maintaining a positive stance on the stock due to its robust financial metrics in Q1.

Q1 Results: A 42% Surge in Consolidated Net Profit

Apollo Hospitals reported a 42% surge in consolidated net profit during the first quarter of the current fiscal to Rs 433 crore, compared to Rs 305 crore in the corresponding period last year. The hospital chain’s topline grew 15% to Rs 5,842 crore compared to Rs 5,086 crore in the year-ago period.

Driving Factors Behind the Growth

Apollo Hospitals Chairman Dr. Prathap C Reddy attributed the strong results to Apollo’s integrated care model and strategic investments in digital platforms and infrastructure. “Our three growth engines—Healthcare Services, Retail Health & Diagnostics, and Digital & Pharma Distribution—have all contributed meaningfully,” he said.

Expansion Plans and Investments

Healthcare services revenue stood at Rs 2,974 crore in Q1FY26 compared to Rs 2,843 crore in Q4FY25 and Rs 2,654 crore in Q1FY25. Apollo plans to add over 4,300 beds over the next five years with an investment of Rs 7,600 crore, including expansions in Bengaluru and Hyderabad.

Expenses and Investments

The expenses were reported at Rs 5,313 crore, made on material used by the hospital, purchases of stock-in-trade, employee benefits, and as finance cost. The Board of Directors approved an investment of Rs 8.5 crore for acquiring 85 lakh equity shares of Apollo Gleneagles PET-CT Private Ltd (AGPCL) from its existing shareholder, Parkway Healthcare (Mauritius) PTE Ltd, representing capital of AGPCL.

Stock Performance and Analyst Views

On Wednesday, shares of Apollo Hospitals opened at Rs 7,395.00 and gained 7.10% intraday to hit a 52-week high of Rs 7,761 so far. At 1:13 pm, shares of Apollo Hospitals traded 6.285 higher at Rs 7,690 apiece on the BSE, against the Sensex index’s rise of 0.42% to 80,571.57.

Analyst Views and Recommendations

Citi has said that Apollo Hospitals remains its preferred hospital stock pick. It has maintained its ‘buy’ rating on Apollo Hospitals with a target price of Rs 8,260 and eyes a potential upside of 13.5% on the stock. Apollo’s consolidated EBITDA came nearly 9% ahead of Citi’s estimates.

Nomura maintained its ‘neutral’ rating on Apollo Hospitals with a target price of Rs 6,856, noting in-line revenue and better-than-expected EBITDA. The brokerage flagged that execution is a key risk for the hospital major with delays in setting up the hospital projects.

Conclusion

Apollo Hospitals share price has gained 9.10% in one week, 11.73% in three months, and 21.3% in six months. The stock has risen nearly 6% on a year-to-date basis and 17.27% in the last 12 months. The relative strength index was 65.23, nearing the overbought territory. The company commands a market cap of Rs 1,10,581.90 crore.

Investors should consult with their own financial or investment adviser before taking any investment decision. Learn more about investing in Indian stocks and stay updated with the latest market news and analysis.